Monday, September 03, 2007 9:02:58 PM
SHARON, PA--(MARKET WIRE)--Mar 27, 2007 -- NanoLogix, Inc. (Other OTC:NNLX.PK - News) announced today that the company has received its first royalty payment from Nutra Pharma (OTC BB:NPHC.OB - News) for the sale and distribution of Nutra Pharma diagnostic test kits, marketed by their wholly owned subsidiary Designer Diagnostics.
http://biz.yahoo.com/iw/070327/0231346.html
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM